Interaction ID
ncRI-40981401
Interaction Molecules
hsa-miR-500a-3p -- FADS2
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
RISE database
Tags
Organism
Homo sapiens
Tissue or Cell Type
HEK293
Experiment
CLASH
Description
RNA-RNA interaction from RISE database
Alias
hsa-miR-500a-5p;MIR500A;hsa-miR-500a
Class
miRNA
miRBase id
Description
Homo sapiens miR-500a stem-loop
Alias
-
Class
mRNA
Ensembl id
ENSG00000134824
Description
Acts as a fatty acyl-coenzyme A (CoA) desaturase that introduces a cis double bond at carbon 6 of the fatty acyl chain. Involved in biosynthesis of highly unsaturated fatty acids (HUFA) from the essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3) precursors. Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n- 3) into gamma-linoleate (GLA) (18:3n-6) and stearidonate (18:4n- 3), respectively (PubMed:12713571). Subsequently, in the biosynthetic pathway of HUFA n-3 series, desaturates tetracosapentaenoate (24:5n-3) to tetracosahexaenoate (24:6n-3), which is then converted to docosahexaenoate (DHA)(22:6n-3), an important lipid for nervous system function (By similarity). Desaturates palmitate to produce the mono-unsaturated fatty acid sapienate, the most abundant fatty acid in sebum (PubMed:12713571). Also desaturates (11E)-octadecenoate (trans- vaccenoate)(18:1n-9), a metabolite in the biohydrogenation pathway of LA (18:2n-6) (By similarity).
Pubmed ID | 23622248 | Journal | Cell |
---|---|---|---|
Title | Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. | ||
Author | Helwak A, Kudla G, Dudnakova T, Tollervey D |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-500a-3p | acute T cell leukemia | MNDR Database |
hsa-miR-500a-3p | Adrenocortical Carcinoma | MNDR Database |
hsa-miR-500a-3p | Alzheimer's disease | MNDR Database |
hsa-miR-500a-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-500a-3p | autosomal recessive disease | MNDR Database |
hsa-miR-500a-3p | autosomal recessive limb-girdle muscular dystrophy type 2B | MNDR Database |
hsa-miR-500a-3p | brain disease | MNDR Database |
hsa-miR-500a-3p | breast cancer | MNDR Database |
hsa-miR-500a-3p | Breast Neoplasms | MNDR Database |
hsa-miR-500a-3p | cancer | MNDR Database |
hsa-miR-500a-3p | carcinoma | MNDR Database |
hsa-miR-500a-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-500a-3p | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-500a-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-500a-3p | chronic lymphocytic leukemia | MNDR Database |
hsa-miR-500a-3p | colon adenocarcinoma | MNDR Database |
hsa-miR-500a-3p | colon cancer | MNDR Database |
hsa-miR-500a-3p | colorectal cancer | MNDR Database |
hsa-miR-500a-3p | dilated cardiomyopathy | MNDR Database |
hsa-miR-500a-3p | distal muscular dystrophy | MNDR Database |
hsa-miR-500a-3p | Down syndrome | MNDR Database |
hsa-miR-500a-3p | eye disease | MNDR Database |
hsa-miR-500a-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-500a-3p | Friedreich ataxia | MNDR Database |
hsa-miR-500a-3p | Gait Ataxia | MNDR Database |
hsa-miR-500a-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-500a-3p | Glioblastoma | MNDR Database |
hsa-miR-500a-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-500a-3p | Heart Failure | MNDR Database |
hsa-miR-500a-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-500a-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-500a-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-500a-3p | interstitial cystitis | MNDR Database |
hsa-miR-500a-3p | leukemia | MNDR Database |
hsa-miR-500a-3p | liposarcoma | MNDR Database |
hsa-miR-500a-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-500a-3p | lung cancer | MNDR Database |
hsa-miR-500a-3p | lung disease | MNDR Database |
hsa-miR-500a-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-500a-3p | lupus nephritis | MNDR Database |
hsa-miR-500a-3p | Lupus Vulgaris | MNDR Database |
hsa-miR-500a-3p | Machado-Joseph disease | MNDR Database |
hsa-miR-500a-3p | malignant glioma | MNDR Database |
hsa-miR-500a-3p | medulloblastoma | MNDR Database |
hsa-miR-500a-3p | melanoma | MNDR Database |
hsa-miR-500a-3p | multiple myeloma | MNDR Database |
hsa-miR-500a-3p | Myasthenia Gravis, Autoimmune, Experimental | MNDR Database |
hsa-miR-500a-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-500a-3p | nephroblastoma | MNDR Database |
hsa-miR-500a-3p | neurodegenerative disease | MNDR Database |
hsa-miR-500a-3p | neuromyelitis optica | MNDR Database |
hsa-miR-500a-3p | ovarian carcinoma | MNDR Database |
hsa-miR-500a-3p | ovarian clear cell carcinoma | MNDR Database |
hsa-miR-500a-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-500a-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-500a-3p | pancreatic cancer | MNDR Database |
hsa-miR-500a-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-500a-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-500a-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-500a-3p | prostate adenocarcinoma | MNDR Database |
hsa-miR-500a-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-500a-3p | renal cell carcinoma | MNDR Database |
hsa-miR-500a-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-500a-3p | retinoblastoma | MNDR Database |
hsa-miR-500a-3p | Seizures | MNDR Database |
hsa-miR-500a-3p | stomach cancer | MNDR Database |
hsa-miR-500a-3p | stomach carcinoma | MNDR Database |
hsa-miR-500a-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-500a-3p | Subarachnoid Hemorrhage, Traumatic | MNDR Database |
hsa-miR-500a-3p | tonsil cancer | MNDR Database |
hsa-miR-500a-3p | urinary bladder cancer | MNDR Database |
hsa-miR-500a-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-500a-3p | vascular disease | MNDR Database |